nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Lipase increased—Sorafenib—liver cancer	0.0621	0.116	CcSEcCtD
Pasireotide—Amylase increased—Sorafenib—liver cancer	0.0383	0.0717	CcSEcCtD
Pasireotide—Prothrombin level increased—Epirubicin—liver cancer	0.0164	0.0307	CcSEcCtD
Pasireotide—Prothrombin level increased—Doxorubicin—liver cancer	0.0152	0.0284	CcSEcCtD
Pasireotide—Pain in extremity—Sorafenib—liver cancer	0.0133	0.0248	CcSEcCtD
Pasireotide—Dry skin—Sorafenib—liver cancer	0.0121	0.0227	CcSEcCtD
Pasireotide—Abdominal pain upper—Sorafenib—liver cancer	0.0121	0.0226	CcSEcCtD
Pasireotide—Hypokalaemia—Sorafenib—liver cancer	0.0121	0.0225	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0119	0.0223	CcSEcCtD
Pasireotide—Nasopharyngitis—Sorafenib—liver cancer	0.0119	0.0221	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Sorafenib—liver cancer	0.0117	0.0218	CcSEcCtD
Pasireotide—Alopecia—Sorafenib—liver cancer	0.0081	0.0151	CcSEcCtD
Pasireotide—Anaemia—Sorafenib—liver cancer	0.00738	0.0138	CcSEcCtD
Pasireotide—Hypertension—Sorafenib—liver cancer	0.00689	0.0129	CcSEcCtD
Pasireotide—Arthralgia—Sorafenib—liver cancer	0.00679	0.0127	CcSEcCtD
Pasireotide—Myalgia—Sorafenib—liver cancer	0.00679	0.0127	CcSEcCtD
Pasireotide—Injection site reaction—Epirubicin—liver cancer	0.00671	0.0125	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—liver cancer	0.00621	0.0116	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00593	0.0111	CcSEcCtD
Pasireotide—Decreased appetite—Sorafenib—liver cancer	0.00566	0.0106	CcSEcCtD
Pasireotide—Diabetes mellitus—Epirubicin—liver cancer	0.00563	0.0105	CcSEcCtD
Pasireotide—Fatigue—Sorafenib—liver cancer	0.00562	0.0105	CcSEcCtD
Pasireotide—Constipation—Sorafenib—liver cancer	0.00557	0.0104	CcSEcCtD
Pasireotide—Gastrointestinal pain—Sorafenib—liver cancer	0.00533	0.00995	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—liver cancer	0.00521	0.00974	CcSEcCtD
Pasireotide—Abdominal pain—Sorafenib—liver cancer	0.00515	0.00962	CcSEcCtD
Pasireotide—Hypoglycaemia—Epirubicin—liver cancer	0.00502	0.00938	CcSEcCtD
Pasireotide—Pain in extremity—Epirubicin—liver cancer	0.0049	0.00915	CcSEcCtD
Pasireotide—Asthenia—Sorafenib—liver cancer	0.00467	0.00873	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—liver cancer	0.00464	0.00868	CcSEcCtD
Pasireotide—Pruritus—Sorafenib—liver cancer	0.00461	0.00861	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—liver cancer	0.00453	0.00847	CcSEcCtD
Pasireotide—Dry skin—Epirubicin—liver cancer	0.00449	0.00839	CcSEcCtD
Pasireotide—Abdominal pain upper—Epirubicin—liver cancer	0.00447	0.00836	CcSEcCtD
Pasireotide—Hypokalaemia—Epirubicin—liver cancer	0.00446	0.00833	CcSEcCtD
Pasireotide—Diarrhoea—Sorafenib—liver cancer	0.00446	0.00833	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00441	0.00824	CcSEcCtD
Pasireotide—Nasopharyngitis—Epirubicin—liver cancer	0.00438	0.00818	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00432	0.00807	CcSEcCtD
Pasireotide—Dizziness—Sorafenib—liver cancer	0.00431	0.00805	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—liver cancer	0.00426	0.00796	CcSEcCtD
Pasireotide—Influenza—Epirubicin—liver cancer	0.00423	0.00791	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—liver cancer	0.00415	0.00776	CcSEcCtD
Pasireotide—Vomiting—Sorafenib—liver cancer	0.00414	0.00774	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—liver cancer	0.00414	0.00773	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—liver cancer	0.00412	0.00771	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00408	0.00763	CcSEcCtD
Pasireotide—Headache—Sorafenib—liver cancer	0.00408	0.00762	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—liver cancer	0.00405	0.00757	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.004	0.00747	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—liver cancer	0.00394	0.00737	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—liver cancer	0.00392	0.00732	CcSEcCtD
Pasireotide—Nausea—Sorafenib—liver cancer	0.00387	0.00723	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—liver cancer	0.00382	0.00714	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—liver cancer	0.00353	0.0066	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—liver cancer	0.00334	0.00624	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—liver cancer	0.00309	0.00577	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—liver cancer	0.00299	0.00559	CcSEcCtD
Pasireotide—Back pain—Epirubicin—liver cancer	0.00285	0.00533	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—liver cancer	0.00277	0.00518	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—liver cancer	0.00273	0.00509	CcSEcCtD
Pasireotide—Vertigo—Epirubicin—liver cancer	0.00265	0.00495	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—liver cancer	0.00264	0.00493	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—liver cancer	0.00255	0.00476	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—liver cancer	0.00252	0.00471	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—liver cancer	0.00251	0.00469	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—liver cancer	0.00251	0.00469	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—liver cancer	0.0025	0.00468	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—liver cancer	0.00245	0.00458	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—liver cancer	0.00236	0.0044	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—liver cancer	0.00232	0.00434	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—liver cancer	0.00232	0.00434	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—liver cancer	0.00232	0.00433	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—liver cancer	0.00225	0.0042	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00219	0.0041	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—liver cancer	0.00218	0.00407	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—liver cancer	0.00209	0.00391	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—liver cancer	0.00208	0.00389	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—liver cancer	0.00208	0.00388	CcSEcCtD
Pasireotide—Constipation—Epirubicin—liver cancer	0.00206	0.00385	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00203	0.00379	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—liver cancer	0.00201	0.00376	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—liver cancer	0.00197	0.00368	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—liver cancer	0.00194	0.00362	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—liver cancer	0.00192	0.00359	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—liver cancer	0.0019	0.00356	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—liver cancer	0.0019	0.00356	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—liver cancer	0.00182	0.0034	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—liver cancer	0.00176	0.00329	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—liver cancer	0.00173	0.00323	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—liver cancer	0.0017	0.00318	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—liver cancer	0.00165	0.00308	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—liver cancer	0.0016	0.00299	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—liver cancer	0.00159	0.00297	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—liver cancer	0.00158	0.00294	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—liver cancer	0.00153	0.00286	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—liver cancer	0.00152	0.00285	CcSEcCtD
Pasireotide—Headache—Epirubicin—liver cancer	0.00151	0.00282	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—liver cancer	0.00147	0.00275	CcSEcCtD
Pasireotide—Nausea—Epirubicin—liver cancer	0.00143	0.00267	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—liver cancer	0.00142	0.00265	CcSEcCtD
Pasireotide—Headache—Doxorubicin—liver cancer	0.0014	0.00261	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—PRKCE—liver cancer	0.00138	0.00297	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR4—liver cancer	0.00136	0.00292	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CSF2—liver cancer	0.00134	0.00289	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—liver cancer	0.00133	0.00286	CbGpPWpGaD
Pasireotide—Nausea—Doxorubicin—liver cancer	0.00132	0.00247	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—PRKCE—liver cancer	0.00132	0.00284	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FST—liver cancer	0.00132	0.00283	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PRKCE—liver cancer	0.00129	0.00278	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CSF2—liver cancer	0.00129	0.00277	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TRIO—liver cancer	0.00125	0.0027	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CSF2—liver cancer	0.00122	0.00262	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FST—liver cancer	0.00121	0.00261	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR4—liver cancer	0.0012	0.00259	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PRKCE—liver cancer	0.00119	0.00256	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PRKCE—liver cancer	0.00117	0.00252	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CSF2—liver cancer	0.00117	0.00252	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TRIO—liver cancer	0.00116	0.00249	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CSF2—liver cancer	0.00114	0.00246	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADAM17—liver cancer	0.00112	0.00241	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR4—liver cancer	0.00111	0.00239	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PRKCE—liver cancer	0.00108	0.00233	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADAM17—liver cancer	0.00107	0.00231	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—F2—liver cancer	0.00105	0.00227	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CSF2—liver cancer	0.00105	0.00227	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PSMD10—liver cancer	0.00105	0.00226	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PSMA4—liver cancer	0.00105	0.00226	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CSF2—liver cancer	0.00104	0.00223	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—F2—liver cancer	0.00101	0.00217	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CG—liver cancer	0.00101	0.00217	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PSMA4—liver cancer	0.00101	0.00217	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PSMD10—liver cancer	0.00101	0.00217	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CG—liver cancer	0.000967	0.00208	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—F2—liver cancer	0.000957	0.00206	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CSF2—liver cancer	0.000957	0.00206	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADAM17—liver cancer	0.000951	0.00205	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—F2—liver cancer	0.000918	0.00197	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CG—liver cancer	0.000916	0.00197	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—F2—liver cancer	0.000896	0.00193	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSMA4—liver cancer	0.000894	0.00192	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSMD10—liver cancer	0.000894	0.00192	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CD—liver cancer	0.000887	0.00191	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CG—liver cancer	0.000878	0.00189	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADAM17—liver cancer	0.000878	0.00189	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CG—liver cancer	0.000858	0.00185	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CD—liver cancer	0.00085	0.00183	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—F2—liver cancer	0.000827	0.00178	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSMD10—liver cancer	0.000825	0.00178	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSMA4—liver cancer	0.000825	0.00178	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRKCE—liver cancer	0.000815	0.00175	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—F2—liver cancer	0.000814	0.00175	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CD—liver cancer	0.000805	0.00173	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CG—liver cancer	0.000792	0.0017	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRKCE—liver cancer	0.000781	0.00168	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CG—liver cancer	0.000779	0.00168	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CB—liver cancer	0.000773	0.00166	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CD—liver cancer	0.000772	0.00166	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF2—liver cancer	0.000772	0.00166	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CD—liver cancer	0.000754	0.00162	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—F2—liver cancer	0.000751	0.00162	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CB—liver cancer	0.000741	0.00159	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF2—liver cancer	0.00074	0.00159	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CSF2—liver cancer	0.000721	0.00155	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—RAF1—liver cancer	0.000719	0.00155	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CG—liver cancer	0.000719	0.00155	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—H2AFX—liver cancer	0.00071	0.00153	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—liver cancer	0.00071	0.00153	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CB—liver cancer	0.000702	0.00151	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CD—liver cancer	0.000696	0.0015	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCE—liver cancer	0.000693	0.00149	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CSF2—liver cancer	0.000691	0.00149	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RAF1—liver cancer	0.000689	0.00148	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CD—liver cancer	0.000685	0.00147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—H2AFX—liver cancer	0.000681	0.00147	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—liver cancer	0.000681	0.00146	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CB—liver cancer	0.000673	0.00145	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CB—liver cancer	0.000657	0.00141	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF2—liver cancer	0.000656	0.00141	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—liver cancer	0.000645	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TERT—liver cancer	0.000642	0.00138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCE—liver cancer	0.000639	0.00138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CD—liver cancer	0.000632	0.00136	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—liver cancer	0.000618	0.00133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TERT—liver cancer	0.000616	0.00132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CSF2—liver cancer	0.000613	0.00132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RAF1—liver cancer	0.000611	0.00132	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CB—liver cancer	0.000607	0.00131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF2—liver cancer	0.000606	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—H2AFX—liver cancer	0.000604	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—liver cancer	0.000604	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—liver cancer	0.000597	0.00128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—liver cancer	0.000588	0.00126	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK14—liver cancer	0.000584	0.00126	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ESR1—liver cancer	0.000573	0.00123	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—F2—liver cancer	0.000566	0.00122	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CSF2—liver cancer	0.000566	0.00122	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RAF1—liver cancer	0.000564	0.00121	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—liver cancer	0.000563	0.00121	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK14—liver cancer	0.00056	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—H2AFX—liver cancer	0.000557	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—liver cancer	0.000557	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—liver cancer	0.000551	0.00119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ESR1—liver cancer	0.000549	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—liver cancer	0.000548	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—liver cancer	0.000546	0.00118	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—F2—liver cancer	0.000542	0.00117	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—liver cancer	0.000541	0.00116	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—liver cancer	0.000541	0.00116	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—liver cancer	0.000519	0.00112	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—liver cancer	0.000519	0.00112	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—liver cancer	0.000509	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—liver cancer	0.000506	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—liver cancer	0.000504	0.00108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—liver cancer	0.0005	0.00107	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK14—liver cancer	0.000496	0.00107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—liver cancer	0.000488	0.00105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ESR1—liver cancer	0.000487	0.00105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—F2—liver cancer	0.000481	0.00103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—liver cancer	0.000476	0.00102	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—liver cancer	0.000471	0.00101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SERPINE1—liver cancer	0.000471	0.00101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—liver cancer	0.000466	0.001	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—liver cancer	0.000461	0.000992	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—liver cancer	0.00046	0.00099	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—liver cancer	0.00046	0.00099	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK14—liver cancer	0.000458	0.000985	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—liver cancer	0.000456	0.000981	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000452	0.000972	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SERPINE1—liver cancer	0.000451	0.000971	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ESR1—liver cancer	0.000449	0.000967	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—liver cancer	0.000447	0.000961	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—F2—liver cancer	0.000444	0.000955	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—liver cancer	0.000433	0.000931	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—liver cancer	0.000428	0.000921	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAF1—liver cancer	0.000425	0.000914	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—liver cancer	0.000425	0.000914	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—liver cancer	0.000425	0.000914	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—liver cancer	0.000415	0.000892	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—liver cancer	0.000415	0.000892	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—liver cancer	0.00041	0.000883	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAF1—liver cancer	0.000407	0.000876	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—liver cancer	0.000405	0.00087	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—liver cancer	0.000401	0.000862	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SERPINE1—liver cancer	0.0004	0.000861	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—liver cancer	0.000399	0.000859	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—liver cancer	0.000398	0.000855	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—liver cancer	0.000398	0.000855	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—liver cancer	0.000396	0.000852	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—liver cancer	0.000396	0.000852	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—liver cancer	0.000389	0.000837	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—liver cancer	0.000385	0.000828	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—liver cancer	0.000381	0.000821	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—liver cancer	0.000381	0.000819	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—liver cancer	0.00038	0.000817	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—liver cancer	0.000379	0.000815	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—liver cancer	0.000373	0.000803	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—liver cancer	0.000373	0.000803	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—liver cancer	0.000371	0.000799	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—liver cancer	0.000371	0.000797	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—liver cancer	0.00037	0.000796	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SERPINE1—liver cancer	0.000369	0.000794	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—liver cancer	0.000369	0.000794	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—liver cancer	0.000368	0.000791	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—liver cancer	0.000366	0.000787	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—liver cancer	0.000366	0.000786	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—liver cancer	0.000365	0.000786	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—liver cancer	0.000364	0.000783	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—liver cancer	0.000363	0.000782	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAF1—liver cancer	0.000361	0.000777	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—liver cancer	0.00036	0.000775	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—liver cancer	0.000359	0.000773	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—liver cancer	0.000356	0.000766	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—liver cancer	0.000355	0.000764	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—liver cancer	0.000353	0.000759	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—liver cancer	0.000353	0.000759	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—liver cancer	0.000353	0.000758	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK8—liver cancer	0.000351	0.000754	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—liver cancer	0.00035	0.000752	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—liver cancer	0.000346	0.000743	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—liver cancer	0.000344	0.000741	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—liver cancer	0.000337	0.000724	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK8—liver cancer	0.000336	0.000723	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—liver cancer	0.000336	0.000722	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—liver cancer	0.000335	0.000721	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAF1—liver cancer	0.000333	0.000717	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—liver cancer	0.000331	0.000712	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—liver cancer	0.000327	0.000704	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—liver cancer	0.000325	0.0007	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—liver cancer	0.000325	0.0007	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—liver cancer	0.000324	0.000698	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—liver cancer	0.000324	0.000697	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—liver cancer	0.000324	0.000696	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—liver cancer	0.000322	0.000693	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—liver cancer	0.000321	0.000689	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—liver cancer	0.000316	0.000679	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—liver cancer	0.000315	0.000678	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—liver cancer	0.000313	0.000673	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—liver cancer	0.000311	0.000668	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—liver cancer	0.00031	0.000668	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—liver cancer	0.000307	0.000661	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—liver cancer	0.000307	0.000659	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—liver cancer	0.000305	0.000657	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—liver cancer	0.000305	0.000657	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—liver cancer	0.000302	0.00065	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—liver cancer	0.000299	0.000644	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—liver cancer	0.000299	0.000643	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK8—liver cancer	0.000298	0.000641	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—liver cancer	0.000298	0.000641	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—liver cancer	0.000297	0.00064	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—liver cancer	0.000297	0.00064	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—liver cancer	0.000297	0.000639	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—liver cancer	0.000291	0.000627	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—liver cancer	0.000291	0.000625	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—liver cancer	0.000289	0.000621	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—liver cancer	0.000286	0.000614	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—liver cancer	0.000285	0.000613	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—liver cancer	0.000283	0.000609	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—liver cancer	0.000282	0.000606	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—liver cancer	0.000275	0.000592	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—liver cancer	0.000275	0.000592	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK8—liver cancer	0.000275	0.000592	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—liver cancer	0.000274	0.00059	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—liver cancer	0.000273	0.000586	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—liver cancer	0.000264	0.000568	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—liver cancer	0.000254	0.000546	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—liver cancer	0.000253	0.000545	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—liver cancer	0.000253	0.000544	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—liver cancer	0.000253	0.000543	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—liver cancer	0.000251	0.000541	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—liver cancer	0.000245	0.000526	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—liver cancer	0.000242	0.000521	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—liver cancer	0.000234	0.000504	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—liver cancer	0.000234	0.000503	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—liver cancer	0.000234	0.000503	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—liver cancer	0.000234	0.000503	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—liver cancer	0.000233	0.000502	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—liver cancer	0.000224	0.000482	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—liver cancer	0.000224	0.000482	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—liver cancer	0.000216	0.000465	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—liver cancer	0.000215	0.000462	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—liver cancer	0.000215	0.000462	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—liver cancer	0.000208	0.000447	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—liver cancer	0.000207	0.000444	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—liver cancer	0.000199	0.000428	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—liver cancer	0.000198	0.000427	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—liver cancer	0.000198	0.000426	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—liver cancer	0.000192	0.000413	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—liver cancer	0.00019	0.00041	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—liver cancer	0.000184	0.000395	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—liver cancer	0.000176	0.000378	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—liver cancer	0.000176	0.000378	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—liver cancer	0.000162	0.000349	CbGpPWpGaD
